Skip to main content

Introduction: Colorectal Cancer

  • Chapter
Colorectal Cancer

Part of the book series: Methods of Cancer Diagnosis, Therapy, and Prognosis ((HAYAT,volume 4))

An immense burden is associated with cancer worldwide. This is especially evident among citizens of developing countries. A case in point is that approximately 500,000 women develop cervical cancer each year worldwide, resulting in 250,000 deaths, and 80% of this cancer occurs in developing countries. Many factors, including socio-economic status, cultural perception of malignant conditions, the cost of anticancer chemotherapy, and the paucity of radiation and hospital facilities, (i.e., cancer screening), insufficient transmission of oncology-related information, and, most importantly, inadequate diet, are responsible for the suffering among those in the developing world. Although efforts are being undertaken by private organizations and institutions for reducing the burden of cancer in developing countries, it is evident that governments of developed countries could do much more to address the problem.

Because significant improvements in the prevention and treatment of cardiovascular diseases have occurred, cancer will become the leading cause of death in many parts of the world. In addition, cancer will remain a major health problem, as population aging continues in many countries and elderly persons are more susceptible to this form of malignancy. Approximately, 60% of cancer incidence and 70% of cancer mortality occur among older adults (65 years and older). Unfortunately, it should be noted that cancer care for frail older adults has been mostly unrepresented in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Petrillo, A., Lastoria, S., Parisi, V., Comella, G., Budillon, A., and Comella, P. 2007. High rate of TRG1-2 and prolonged RFS with OXA/ TOM and FU/LFA during preoperative pelvic RT in patients with poor prognosis locally advanced rectal cancer (LARC). J. Clin. Oncol. 25: 14500.

    Google Scholar 

  • Berends, F.J., Kazemier, G., Bonjer, H.J., and Lange, J.F. 1994. Subcutaneous metastasis after laparoscopic colectomy. Lancet 344: 58.

    Article  PubMed  CAS  Google Scholar 

  • Berger, B.M., Vucson, B.M., and Diteberg, J.S. 2003. Gene mutations in advanced colonic polyps: potential worker selection for stool-based mutated human DNA assays for colon cancer screening. Clin. Colorect. Cancer 3: 180–185.

    Article  CAS  Google Scholar 

  • Bodmer, W.F., Bailey, C.J., Bodmer, J., Bussey, H.J., Ellis, A., Gorman, P., Lucibello, F.C., Murday, A.V., Rider, S.H., Scambler, P., Solomon, S.E., and Spurr, N.K. 1987. Localization of the gene for familial adenomatous polyposis and chromosome 5. Nature 328: 614–616.

    Article  PubMed  CAS  Google Scholar 

  • de Boer, J.G. 2002. Polymorphisms in DNA repair and environmental interactions. Mutat. Res. 509: 201–210.

    PubMed  Google Scholar 

  • Booth, R.A. 2007. Minimally invasive biomarkers for detection and staging of colorectal cancer. Cancer Lett. 249: 87–96.

    Article  PubMed  CAS  Google Scholar 

  • Bronner, C.E., Baker, S.M., Morrison, P.T., Warren, G., Smith, L.G., Lescoe, M.K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., Tannergard, P., Bollag, R.J., Godwin, A.R., Ward, D.C., Nordenskjold, M., Fishel, R., Kolodner, R., Liskay, R.M. 1994. Mutation in the DNA mismatch repair gene homologue hMLHI is associated with hereditary nonpolyposis colon cancer. Nature 368: 258–261.

    Article  PubMed  CAS  Google Scholar 

  • Coussens, L.M., and Werb, Z. 2002. Inflammation and Cancer. Nature 420: 860–867.

    Article  PubMed  CAS  Google Scholar 

  • Douillard, J.Y., Cunningham, D., and Roth, A.D. 2000. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multi-center radomised trial. Lancet 355: 1041–1047.

    Article  PubMed  CAS  Google Scholar 

  • Giantonio, B.J., Catalano, P.J., Meropol, N.J., O'Dwyer, P.J., Mitchell, E.P., Alberts, S.R., Schwartz, M.A., and Benson III, A.B. 2007. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J. Clin. Oncol. 25: 1539–1544.

    Article  PubMed  CAS  Google Scholar 

  • Goldberg, R.M., Sargent, D.J., Morton, R.F., Fuchs, C.S., Ramanathan, R.K., Williamson, S.K., Findlay, B.P., Pitot, H.C., and Alberts, S. 2006. Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irino-tecan or infused fluorouracil plus oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J. Clin. Oncol. 24: 3347–3352.

    Article  PubMed  CAS  Google Scholar 

  • Imperiali, G., Minoli, G., Meucci, G.M., Spinzl, G., Strocchi, E., Terruzzi, V., and Radaelli, F. 2007. Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy 39: 314–318.

    Article  PubMed  CAS  Google Scholar 

  • Imperiale, T.F., Ransohoff, D.F., Itzkowitz, S.H., Turnbell, B.A., Ross, M.E., and Colorectal Cancer Study Group. 2004. Fecal DNA versus fecal occult blood for colorectal cancer screening in an average-risk population. N. Engl. J. Med. 351: 2704–2714.

    Article  PubMed  CAS  Google Scholar 

  • Issa, J.P., Shen, L., and Toyota, M. 2005. CIMP, at last. Gastroenterology 129: 1121–1124.

    Article  PubMed  CAS  Google Scholar 

  • Jackson, T.D., Kaplan, G.G., Arena, G., Page, J.H., and Regers, Jr., S.O. 2007. Laparoscopic versus open resection for colorectal cancer: a meta-annalysis of oncologic outcomes. J. Am. Coll. Surg. 204: 439–446.

    Article  PubMed  Google Scholar 

  • Jeroen, C., Reitsma, J.B., Stoker, J., Bossuyt, P.M., van Deventer, S.J., and Dehker, E. 2006. Polypmissrate determined by tandem colonoscopy: a systematic review. Am. J. Gastroenterol. 101: 343–350.

    Article  Google Scholar 

  • Johnson, K.T., Carston, M.J., Wentz, R.J., Manduca, A., Anderson, S.M., and Johnson, C.D. 2007. Development of cathartic-free colorectal cancer screening. Test using virtual colonoscopy: a feasibility study. Am. J. Radiol. 188: W29–W36.

    Google Scholar 

  • Loktionov, A. 2007. Cell exfoliation in the human colon: myth, reality and implications for color-ectal cancer screenings. Int. J. Cancer 120: 2281–2289.

    Article  PubMed  CAS  Google Scholar 

  • Minami, S., Furui, J., and Kanematsu, T. 2001. Role of carcinoembryonic antigen in the progression of colon cancer cells that express carbohydrate antigen. Cancer Res. 61: 2732–2735.

    PubMed  CAS  Google Scholar 

  • Nakayama, G., Hibi, K., Nakayama, H., Kodera, Y., Ito, K., Akiyama, S., and Nakao, A. 2007. A highly sensitive method for the detection of p16 methylation in the serum of colorectal cancer patients. Anticancer Res. 27: 1459–1464.

    PubMed  CAS  Google Scholar 

  • Pawlik, T.M., Scoggins, C.R., Zorzi, D., Abdalla, E.K., Andres, A., Eng, C., Curley, S.A., Loyer, E., Muratore, A., Mentha, G., Caoussotti, L., and Vauthey, J.N. 2005. Effects of surgical margin status on survival and site recurrence after hepatic resection for colorectal metastases. Ann. Surg. 241: 715–722.

    Article  PubMed  Google Scholar 

  • Ren, J., Xiao, Y.J., Singh, L.S., Zhao, X., Zhao, Z., Feng, L., Rose, T.M., Prestwich, G.D., and Xu, Y. 2006. Lysophosphatidic acid is continually produced by human peritoneal mesothelial cells and enhances adhesion, migration and invasion of ovaria cancer cells. Cancer Res. 66: 3006–3014.

    Article  PubMed  CAS  Google Scholar 

  • Rockey, D.C., Paulson, E., Niedzwiechi, D., Davis, W., Bosworth, H.B., Sanders, L., Yee, J., Henderson, J., Haften, P., Burdich, S., Sanyal, A., Rubin, D.T., Sterlin, M., Aberkar, G., Bhutani, M.S., Binmoeller, K., Garvie, J., Bini, E.J., McQuaid, K., Foster, W.L., Thompson, W.M., Dachman, A., and Halvorsen, R. 2005. Analysis of air contrast barium enema, computed tomo-graphic colonography and colonoscopy: prospective comparison. Lancet 365: 305–311.

    PubMed  CAS  Google Scholar 

  • Simiantonaki, N., Kurzik-Dumke, U., Karyofylli, G., Tayasinghe, C., Michel-Schmidt, R., and Kirkpatrick, C.J. 2007. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Inter. J. Mol. Med. 20: 21–29.

    CAS  Google Scholar 

  • Wilson, J., and Balkwill, F. 2002. The role of cytokines in the epithelial cancer microenviron-ment. Semin. Cancer Biol. 12: 113–120.

    Article  PubMed  CAS  Google Scholar 

  • Yeh, C.C., Sung, F.C., Tang, R., Chung-Rong, C.C. and Hsieh, L.L. 2007. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J. Biomed. Sci. 14: 183–193.

    Article  PubMed  CAS  Google Scholar 

  • Zhao, Z., Xiao, Y., Elson, P., Tan, H., Plummer, S.J., Berk, M., Aung, P.U.,Lavery, I.C., Achbar, J.P., Li, L., Casey, G., and Xu, Y. 2007. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal cancer. J. Clin. Onc. 25: 2696–2701.

    Article  CAS  Google Scholar 

  • Zorzi, D., Laurent, A., Pawlik, T.M., Lauwers, G.Y., Vauthey, J.N., and Abdalla, E.K. 2007. Chemotherapy associated hepatotoxicity and surgery for colorectal liver metastases. Brit. J. Surg. 94: 274–286.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science + Business Media B.V.

About this chapter

Cite this chapter

Hayat, M.A. (2009). Introduction: Colorectal Cancer. In: Hayat, M.A. (eds) Colorectal Cancer. Methods of Cancer Diagnosis, Therapy, and Prognosis, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-9545-0_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-9545-0_1

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-9544-3

  • Online ISBN: 978-1-4020-9545-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics